At Gilead, our purpose is to create a healthier world for all people. We continue to confront the biggest public health challenges of our day and make the impossible possible by investing in worldclass science, addressing societal barriers to care and building a culture where our employees can make a real impact together.
HIV: We are leading the charge to end the epidemic for everyone, everywhere, from the first single tablet regimen to treat HIV, to medicines that help prevent it, to our continued search for a cure.
Viral Hepatitis: We have helped cure millions of people with hepatitis C. As we work to eliminate it by 2030, we are also providing options for people with hepatitis B and D.
COVID-19: We delivered the first approved treatment for COVID-19, now available in 170+ countries. Our research and preparation for future public health crises is ongoing.
We are on our way to becoming a top 10 oncology company by 2030 and eventually curing certain cancers through cell therapy. Together with Kite, we have built a world-class oncology portfolio with nearly 50 clinical-stage programs across nearly every tumor type.
We are advancing an early pipeline of potentially best-in-class molecules to control chronic inflammatory and fibrotic diseases.